We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other psychedelic ...

Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

Johnson's passion for helping others led her ... didn’t think she was smart or worthy or worth being loved … suffering from depression and suicidal ideation – I would say to that little ...

Stifel has initiated Compass Pathways (NASDAQ:CMPS) with a buy rating saying that stakeholders are starting to agree there is ...

Mr Johnson is an American entrepreneur and venture ... of Latter-day Saints when he was 24 after falling into a deep depression that lasted 10 years. He said in an August 2023 interview on The ...

Missouri lawmakers consider a study on psilocybin therapy to aid veterans with PTSD and depression. Despite initial ...

Despite changes over the years, the legacy of Jackson Street continues to resonate, with a new generation of musicians and ...

Johnson & Johnson’s seltorexant is one of two new therapies that the company reckons could become blockbuster treatments for depression, and data from a phase 3 trial keeps that hope alive.

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity ... That status goes to Johnson & Johnson's Spravato (esketamine), which was approved in March ...

"Last year’s spring break was a success on any level you measure it," Miami Beach Mayor Steven Meiner said. “We had zero ...